TargAnox Garners $5,100,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e889f026-4af2-4ce4-89c4-673e6fc06873&Preview=1
-
Date
3/30/2009
-
Company Name
TargAnox
-
Mailing Address
101 Huntington Avenue, 4th Floor Boston, MA 02199
-
Company Description
TargAnox is focused on developing drugs to curb a sometimes disease-related biochemical condition called oxidative stress.
-
Website
Undisclosed
-
Transaction Type
Venture Equity
-
Transaction Amount
$5,100,000
-
Transaction Round
Series A
-
Proceeds Purposes
Proceeds purposes were not disclosed.
-
M&A Terms
-
Venture Investor
Ascent Biomedical Ventures
-
Venture Investor
Partners Innovation Fund
-
Venture Investor
Partners HealthCare System
Add Your Thoughts
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.